Promising Outcomes in APL Treatment – ACS Journal Cancer
ACS Journal Cancer posted the following on X:
“Just published! Explore the encouraging long-term outcomes of all-trans retinoic acid, arsenic trioxide, and gemtuzumab ozogamicin in a large cohort of patients with APL.”
Authors: Wei-Ying Jen BM, BCh, Jennifer Marvin-Peek MD, Hagop M. Kantarjian MD, Yesid Alvarado MD, Gautam Borthakur MD, Elias Jabbour MD, William Wierda MD, Tapan M. Kadia MD, Naval G. Daver MD, Courtney D. DiNardo MD, Nicholas J. Short MD, Nitin Jain MD, Alessandra Ferrajoli MD, Steven Kornblau MD, Musa Yilmaz MD, Maro Ohanian MD, David McCue BSc, Jan Burger MD, Danielle Hammond MD, Keyur Patel MD, Ghayas C. Issa MD, Naveen Pemmaraju MD, Koji Sasaki MD, Abhishek Maiti MD, Hussein A. Abbas MD, Kelly Chien MD, Koichi Takahashi MD, Fadi Haddad MD, Prithviraj Bose MD, Lucia Masarova MD, Guillermo Montalban-Bravo MD, Mahesh Swaminathan MD, Mark Brandt BS, Sherry Pierce BA, BSN, Guillermo Garcia-Manero MD, Farhad Ravandi MD
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023